ENTYVIO may cause serious side effects, including: • Infusion-related and serious allergic reactions can happen while you are receiving ENTYVIO or several hours after treatment. You …

See ENTYVIO treatment options, infusion and subcutaneous injection, for Crohn's disease and ulcerative colitis. See Safety and Prescribing Information.

If anaphylaxis or other serious infusion-related or hypersensitivity reactions occur, discontinue administration of ENTYVIO immediately and initiate appropriate treatment. Infections: Patients …

THE ENTYVIO PEN The ENTYVIO Pen is approved for the treatment of moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD) after at least 2 intravenous (IV) …

Oct 27, 2025 · For those battling ulcerative colitis, entyvio vedolizumab treatment for ulcerative colitis patients offers targeted relief by focusing on gut inflammation without broadly …

Apr 15, 2025 · Entyvio (vedolizumab) is FDA-approved for the treatment of moderate to severe active ulcerative colitis and Crohn’s disease in adults. It is reserved for patients who have had …

A patient support program designed to make your journey as stress-free as possible, EntyvioConnect is available to ENTYVIO patients by signing up here. EntyvioConnect ofers …

Patients responding to ENTYVIO IV after Week 6 may be switched to ENTYVIO SC. Administer the first SC dose in place of the next scheduled IV infusion and Q2W thereafter Choose the …

ENTYVIO offers 2 flexible administration options that support your treatment journey. You and your healthcare provider can select IV infusion or a self-administered injection with the …

ENTYVIO should be discontinued in patients with jaundice or other evidence of significant liver injury. Live and Oral Vaccines: Prior to initiating treatment with ENTYVIO, all patients should …